HUB Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Buy
1,700
+1,300
+325% +$1.33M 0.04% 300
2026
Q1
$368K Sell
400
-800
-67% -$811K 0.01% 705
2025
Q4
$1.29M Sell
1,200
-400
-25% -$382K 0.03% 261
2025
Q3
$1.22M Sell
1,600
-200
-11% -$149K 0.04% 255
2025
Q2
$1.4M Buy
1,800
+900
+100% +$699K 0.05% 227
2025
Q1
$743K Sell
900
-500
-36% -$416K 0.03% 272
2024
Q4
$183K Buy
1,400
+900
+180% +$745K 0.01% 512
2024
Q3
$169K Buy
500
+100
+25% +$89.9K 0.01% 489
2024
Q2
$362K Sell
400
-2,300
-85% -$1.84M 0.01% 329
2024
Q1
$2.1M Sell
2,700
-6,800
-72% -$4.84M 0.11% 138
2023
Q4
$5.54M Buy
9,500
+900
+10% +$525K 0.38% 67
2023
Q3
$4.62M Buy
+8,600
New +$4.43M 0.7% 36
2023
Q1
Sell
-20,000
Closed -$7.32M 241
2022
Q4
$7.32M Buy
+20,000
New +$7.09M 1.6% 12

Other funds holding LLY

HUB Investment Partners's LLY Position: Q2 2026 in Review

HUB Investment Partners increased its Eli Lilly (LLY) stake by 8.2% in Q2 2026, buying an estimated $1.15M and bringing the position to 14,924 shares worth $17.9M. The position accounts for 0.32% of the portfolio, ranked #59.

HUB Investment Partners first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. The position peaked at $18.2M in Q3 2024. 2,244 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HUB Investment Partners held 14,924 shares of Eli Lilly worth $17.9M as of Q2 2026.
  • HUB Investment Partners bought 1,127 Eli Lilly shares in Q2 2026, an estimated $1.15M.
  • Eli Lilly made up 0.32% of HUB Investment Partners's portfolio in Q2 2026, its #59 holding.
  • HUB Investment Partners first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • HUB Investment Partners's Eli Lilly position peaked at $18.2M in Q3 2024.
  • 2,244 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.